ABBV vs. ASND: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABBV and ASND, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABBV dominates in value with a market cap of 321.13 billion USD, eclipsing ASND’s 9.55 billion USD by roughly 33.64×.
With betas of 0.55 for ABBV and 0.40 for ASND, both show similar volatility profiles relative to the overall market.
ASND is an ADR, letting U.S. buyers tap its non-U.S. business directly, unlike ABBV, which is purely domestic.
Symbol | ABBV | ASND |
---|---|---|
Company Name | AbbVie Inc. | Ascendis Pharma A/S |
Country | US | DK |
Sector | Healthcare | Healthcare |
Industry | Drug Manufacturers - General | Biotechnology |
CEO | Mr. Robert A. Michael CPA | Mr. Jan Moller Mikkelsen |
Price | 181.8 USD | 158.1 USD |
Market Cap | 321.13 billion USD | 9.55 billion USD |
Beta | 0.55 | 0.40 |
Exchange | NYSE | NASDAQ |
IPO Date | January 2, 2013 | January 28, 2015 |
ADR | No | Yes |
Performance Comparison
This chart compares the performance of ABBV and ASND over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ABBV and ASND based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- ASND shows a negative P/E of -24.59, highlighting a year of losses, whereas ABBV at 76.62 trades on solid profitability.
- ASND shows a negative forward PEG of -2.23, signaling expected earnings contraction, while ABBV at 7.16 maintains analysts’ projections for stable or improved profits.
- ASND carries a sub-zero price-to-book ratio of -44.27, indicating negative equity. In contrast, ABBV (P/B 226.35) has positive book value.
- ASND reports a negative Price-to-Free Cash Flow ratio of -27.48, showing a cash flow shortfall that could threaten its operational sustainability, while ABBV at 20.87 maintains positive cash flow.
Symbol | ABBV | ASND |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | 76.62 | -24.59 |
Forward PEG Ratio (TTM) | 7.16 | -2.23 |
Price-to-Sales Ratio (P/S, TTM) | 5.60 | 22.92 |
Price-to-Book Ratio (P/B, TTM) | 226.35 | -44.27 |
Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.87 | -27.48 |
EV-to-EBITDA (TTM) | 23.58 | -35.80 |
EV-to-Sales (TTM) | 6.73 | 23.82 |
EV-to-Free Cash Flow (TTM) | 25.08 | -28.55 |
Dividend Comparison
ABBV delivers a 3.51% dividend yield, blending income with growth, whereas ASND appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.
Symbol | ABBV | ASND |
---|---|---|
Dividend Yield (TTM) | 3.51% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABBV and ASND, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ABBV’s current ratio of 0.76 signals a possible liquidity squeeze, while ASND at 1.04 comfortably covers its short-term obligations.
- Both ABBV (quick ratio 0.64) and ASND (quick ratio 0.71) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
- ABBV carries high leverage (debt-to-equity ratio 49.22), whereas ASND has negative equity (-4.46), each presenting distinct capital-structure concerns.
- ABBV meets its interest obligations (ratio 6.14). In stark contrast, ASND’s negative ratio (-3.72) means its operating earnings (EBIT) don't cover basic operations, let alone interest, signaling serious financial trouble.
Symbol | ABBV | ASND |
---|---|---|
Current Ratio (TTM) | 0.76 | 1.04 |
Quick Ratio (TTM) | 0.64 | 0.71 |
Debt-to-Equity Ratio (TTM) | 49.22 | -4.46 |
Debt-to-Assets Ratio (TTM) | 0.51 | 0.80 |
Interest Coverage Ratio (TTM) | 6.14 | -3.72 |